Skip to main content
OpenTrials

Clinical trial condition

Metastasis

Explore clinical trials studying Metastasis. Study availability and eligibility vary by location and protocol.

87 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Metastasis trial results

Recruiting

Somatostatin Receptor PET/CT in SSTR-Related Disease Patients

NCT06690957

Conditions
Metastasis, Neoplasm Metastasis, Neoplasms, +6 more
Locations
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases

NCT06690736

Conditions
CXCR4-related Disease, Metastasis, Neoplasm Metastasis, +6 more
Locations
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

FAPI PET/CT in Various FAP-Related Disease Patients

NCT06688071

Conditions
FAP-related Disease, Metastasis, Neoplasm Metastasis, +6 more
Locations
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

NCT06863272

Conditions
Castration-Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +14 more
Locations
  • UCLA Hematology & Oncology ( Site 0003) Los Angeles, California, United States
  • University of California-Irvine Medical Center ( Site 0016) Orange, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0034) San Francisco, California, United States
  • MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) Washington D.C., District of Columbia, United States
View all 82 locations
View Trial Details
Recruiting

Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

NCT06993506

Conditions
Disease Attributes, HER2-negative Breast Cancer, Metastasis, +6 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
View all 19 locations
View Trial Details
Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions
ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Florida Cancer Specialists Lake Mary, Florida, United States
  • Dartmouth Hitchcock Lebanon, New Hampshire, United States
  • Brown University Health Cancer Institute Providence, Rhode Island, United States
View Trial Details

Related conditions